The cell wall skeleton of Nocardia rubra, a new class II biological drug, has been in good operation since it was put into production

The cell wall skeleton of Nocardia rubra produced by Liaoning gerst biopharmaceutical Co., Ltd located in the high tech Zone has been in good operation since it was put into production in August It is reported that the product has a very definite curative effect on cervical cancer, and the company expects the product sales to reach 2 billion yuan within 5 years There is only one workshop, one production line, and only one biological product - cell wall skeleton of Nocardia rubra At gerst's finished product warehouse, the reporter saw the cell wall skeleton of Nocardia rubra, a small glass tube injection bottle with a round powder solid inside "Don't underestimate it," Shi Mingsheng, the company's technical director, told reporters "Gerst's research and development on the cell wall skeleton of Nocardia rubra has lasted for more than 30 years." The cell wall skeleton of Nocardia rubra belongs to the second class of national new biological drugs It not only enjoys the protection of invention patents, but also has 7 domestic and international invention patents It is also a product that fills the gap in the treatment of cervical cancer at home and abroad Shi Mingsheng said: "at present, it is known that the cause of cervical cancer is due to human papillomavirus (HPV) infection The cytoskeleton of Nocardia rubra cell wall is exactly the treatment of HPV, which has a very exact effect on cervical cancer However, foreign countries can only prevent cervical cancer, which has no therapeutic function "As long as this product is effective, we can buy it for as much money as possible," said the chief of cervical cancer Department of Shanghai Hongfang hospital, the most authoritative cervical cancer treatment company in China In 2012, gerst signed a contract to settle in the pharmaceutical capital of China, covering an area of 68 Mu and a building area of 15000 square meters, including office buildings, workshops, substations, animal laboratories and other facilities According to Shi Mingsheng, a batch of products can be produced within 51 days in the workshop, and 40000 pieces of external red Nocardia cell wall skeletons can be produced in one batch for the treatment of cervical erosion, chronic cervicitis, human papillomavirus (HPV) infection, cervical precancerous lesions and cervical cancer The annual output of this product can reach 10 million pieces.